Literature DB >> 16468069

[Pregnancy and immunomodulatory therapy in multiple sclerosis patients].

L A Hoffmann1, T Kümpfel, I Heer, R Hohlfeld.   

Abstract

Pregnancy and family planning issues are prominent concerns in the medical care of multiple sclerosis patients, since the disease onset often coincides with a period of life that is decisive in this regard. Multiple sclerosis is a chronic disorder with an unpredictable course and is widely treated with long-term immunomodulatory agents, raising questions regarding the complications and effects of these therapies on pregnancy. This paper gives an overview of the relevant literature and provides a basis for individual counselling of this group of multiple sclerosis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16468069     DOI: 10.1007/s00115-006-2053-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Pregnancy and multiple sclerosis: a 2-year experience.

Authors:  R Orvieto; R Achiron; Z Rotstein; S Noy; I Bar-Hava; A Achiron
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-02       Impact factor: 2.435

2.  The relapse rate of multiple sclerosis changes during pregnancy: a cohort study.

Authors:  G Salemi; G Callari; M Gammino; F Battaglieri; E Cammarata; G Cuccia; M D'Amelio; I Lupo; P Ragonese; G Savettieri
Journal:  Acta Neurol Scand       Date:  2004-07       Impact factor: 3.209

3.  Intravenous immunoglobulins, pregnancy and multiple sclerosis.

Authors:  Christian Confavreux
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

4.  The effect of pregnancy on multiple sclerosis and its management.

Authors:  A J B TILLMAN
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

5.  Effects of pregnancy and delivery on disease activity in multiple sclerosis.

Authors:  J N Whitaker
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

6.  Epidural analgesia for patients with chronic neurological disease.

Authors:  J S Crawford
Journal:  Anesth Analg       Date:  1983-06       Impact factor: 5.108

7.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

8.  Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients.

Authors:  E Roullet; M H Verdier-Taillefer; P Amarenco; G Gharbi; A Alperovitch; R Marteau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

9.  Pregnancy and multiple sclerosis. A prospective study.

Authors:  A D Sadovnick; K Eisen; S A Hashimoto; R Farquhar; I M Yee; J Hooge; L Kastrukoff; J J Oger; D W Paty
Journal:  Arch Neurol       Date:  1994-11

10.  The clinical course of multiple sclerosis during pregnancy and the puerperium.

Authors:  K Birk; C Ford; S Smeltzer; D Ryan; R Miller; R A Rudick
Journal:  Arch Neurol       Date:  1990-07
View more
  4 in total

1.  Immunomodulation and postpartum relapses in patients with multiple sclerosis.

Authors:  Kerstin Hellwig; Christian Beste; Sebastian Schimrigk; Andrew Chan
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

2.  9 Human Immunoglobulins.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 3.  [Intravenous immunoglobulins in multiple sclerosis. An update].

Authors:  S Schwarz; H-M Meinck; B Storch-Hagenlocher
Journal:  Nervenarzt       Date:  2009-08       Impact factor: 1.214

4.  [Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding].

Authors:  F Hoffmann; A Kraft; F Heigl; E Mauch; J Koehler; L Harms; T Kümpfel; W Köhler; R Klingel; C Fassbender; S Schimrigk
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.